Molecular Partners (MOLN) Stock: Buy, Sell, or Hold?
MOLN - Molecular Partners AG American Depositary Shares
$4.18
-0.17 (-3.91%)
âŧ
5d:
-7.11%
30d:
+6.36%
90d:
+3.21%
WAIT
LOW Confidence
Analysis Updated: Sep 10, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Get Alerted When MOLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MOLN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MOLN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MOLN is currently trading at $4.18, which is considered slightly low relative to its 30-day fair value range of $4.15 to $4.44. From a valuation perspective, the stock is trading at a discount (Forward PE: -30.7) compared to its historical average (31.9). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MOLN is showing sideways momentum. The price is currently testing key support at $4.07. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: MOLN scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.67 (+155.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MOLN is showing sideways momentum. The price is currently testing key support at $4.07. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: MOLN scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.67 (+155.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.15 -
$4.44
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 155.2% below Wall St target ($10.67)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.15 -
$4.44
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.07
Resistance Level
$4.67
Current Trend
Sideways
Technical data as of
Sep 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-30.74
Wall Street Target
$10.67
(+155.2%)
Revenue Growth (YoY)
-100.0%
PE vs Historical
-30.7 vs 31.9
CHEAP
Share & Embed Analysis
Last updated: September 12, 2026 11:46 PM ET
Data refreshes hourly during market hours. Next update: 12:46 AM
Data refreshes hourly during market hours. Next update: 12:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MOLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 41 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
BUY
20 analysts |
$34 | 52 HOLD |
